Greenberg Lab masthead
School of MedicineUniversity of Washington • Box 357735 • 1705 NE Pacific St • Seattle WA 98195

RDP Forum


Funding Announcment

Pilot and Feasability Project

The UW Cystic Fibrosis Research Development Program (CF-RDP) is requesting applications for Pilot and Feasibility (P&F) Projects to be included in the competing renewal for the UW CF-RDP grant to be submitted February 1, 2015. Upon successful award of the competing renewal, each research project will provide an investigator with $50,000 (direct costs) per year for two years. We encourage translational projects that make use of patient materials that can be funded for up to $80,000 per year for two years. Translational research excludes exposing patients to experimental medicines and/or devices, using HIPAA protected patient information and using clinical samples obtained prospectively solely for the purposes of the translational project. No indirect costs are awarded by the Cystic Fibrosis Foundation on these projects.

Application Due Date: November 10, 2014

More info…

Educational Research Seminar Series

Calprotectin and Neutrophil Death in CF

presented by special guest

Dr Robert Gray, MCRP, PhD

Wellcome Trust Intermediate Fellow
University of Edinburgh — Scotland
MRC Center for Inflammation Research

Friday, October 17, 2014
3:00pm – 4:00pm
University of Washington
Health Sciences Building
1705 NE Pacific St., K-069

More info…




E Peter Greenberg

E. Peter Greenberg, Ph.D.

A note from the directors spacer Bonnie Ramsey, M.D.

Bonnie Ramsey, M.D.

The Cystic Fibrosis Foundation supported Research Development Program is in its 24th year of funding at the University of Washington and its research emphasis continues to be Pseudomonas aeruginosa biology, host immune responses, and clinical research. Our mission is to:

  • Foster collaboration among researchers in the field of cystic fibrosis
  • Bring new researchers into the CF field, both established investigators whose area of research expertise enriches the CF program and young investigators initiating academic careers
  • Publish the results of RDP supported projects in peer-reviewed journals
  • And of course, most of all, improve the lives of individuals with cystic fibrosis by providing fundamental knowledge that can lead to development of new and improved therapeutics and patient care

The strength of our program has resulted from two key factors:

  1. A strong relationship between basic and clinical scientists nurturing translational research
  2. Program flexibility permitting the UW RDP to evolve in response to new research developments and initiatives, both within and outside the University

The Program is a university-wide initiative; it has involved faculty from 15 departments. The Program maintains core facilities for use by cystic fibrosis researchers, funds pilot research projects, and supports fellows involved in cystic fibrosis research. We also sponsor research seminars and organize a retreat for cystic fibrosis researchers.

Cycstic Fibrosis Foundation University of Washington